Carmen Vicente
- Hematology top 2%
- Acute Myeloid Leukemia Research 16
- Chronic Myeloid Leukemia Treatments 5
- Cancer Research top 10%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
-
- Acute Lymphoblastic Leukemia research 6
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Jan CoolsMaría D. OderoTiziana GirardiKim De KeersmaeckerFrancisco TiradoA. Pascual-MontanoMiguél VázquezPedro Carmona‐Sáez
- Cited by
- HematologyCancer ResearchGenetics
- Partner nations
- SpainBelgiumUnited States
In The Last Decade
Carmen Vicente
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Hematology 429
- Cancer Research 293
- Genetics 204
- Molecular Biology 1.0k
- Public Health, Environmental and Occupational Health 334
Countries citing papers authored by Carmen Vicente
This map shows the geographic impact of Carmen Vicente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Vicente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Vicente more than expected).
Fields of papers citing papers by Carmen Vicente
This network shows the impact of papers produced by Carmen Vicente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Vicente. The network helps show where Carmen Vicente may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carmen Vicente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 22 | |
| 5 | 2020 | 28 | |
| 6 | 2019 | 33 | |
| 7 | 2019 | 33 | |
| 8 | 2018 | 70 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 59 | |
| 11 | 2016 | 40 | |
| 12 | HEDGEHOG PATHWAY ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS RESPONSE TO SMO AND GLI1 INHIBITORS | 2016 | 1 |
| 13 | 2016 | 14 | |
| 14 | 2015 | 113 | |
| 15 | 2014 | 15 | |
| 16 | 2011 | 126 | |
| 17 | 2010 | 31 | |
| 18 | 2009 | 365 | |
| 19 | 2008 | 21 | |
| 20 | 2007 | 11 |
About Carmen Vicente
Carmen Vicente is a scholar working on Hematology, Genetics and Molecular Biology, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (429 citations), Cancer Research (293 citations) and Genetics (204 citations). Carmen Vicente has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Jan Cools, María D. Odero, Tiziana Girardi, Kim De Keersmaecker, Francisco Tirado, A. Pascual-Montano, Miguél Vázquez, Pedro Carmona‐Sáez, Xiaoyuan Yang and Rubén Nogales‐Cadenas. Their work appears in journals such as Nucleic Acids Research, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.